high5md
@high5md
Followers
741
Following
575
Media
316
Statuses
470
Concise and in-depth coverage of the most important conferences in the field of oncology and immunology on https://t.co/yFzLYjr9O7 & https://t.co/B2U4TlQCrw
Joined July 2021
💡Missed out on #ESMO2025? Watch the top updates on breast cancer now on high5oncologyTV – including key clinical trials and expert takeaways. 📽️For HCPs, free and on demand. 📺 Watch here: https://t.co/Bl2FKaQirc
#BreastCancer #Mammakarzinom #OncologyEducation
0
2
5
Our collaborators at high5Oncology have brought together leading international experts in GU cancer, and their insights are now available online—follow for the latest news and expert analysis from Berlin! https://t.co/zqMCbhSmcq
@amerseburger @EfstathiouEleni @weoncologists
2
8
11
“Very few negatives — only positives here.” Dr. @StephenVLiu wraps up #ESMO2025 in Berlin with his expert insights on HARMONi-6, OptiTROP-Lung04 & a surprise from NorthStar. 🎥 Watch the reports now via high5oncologyTV #LungCancer #Oncology #high5oncologyTV
@OncoAlert
0
7
37
Our Collaborators at @high5md have gathered top international experts in Lung Cancer and have commenced their full reports from ESMO25. Visit them for the Top News out of Berlin! WATCH HERE: https://t.co/zqMCbhSmcq
0
6
8
🎬 The #ESMO25 highlights are live on High5OncologyTV! 💡 Expert analyses 📊 Top data across tumor types 📺 Free & on demand for HCPs: 🔗 https://t.co/SWghforE3H
#ESMO2025 #Oncology #CancerResearch #MedEd
0
1
1
Dear Colleagues at #ESMO25 Our Collaborators at High5Oncology are here in Berlin capturing some great meeting content and special interviews from some of the leading experts in the field. Visit them at👉 https://t.co/m0mOunLZMc
0
4
8
Top #GUcancer abstracts at #ESMO25 via #high5oncologyTV: 🔹 LBA6: Lu-PSMA-617 + ADT/ARPI (mHSPC) 🔹 LBA2: EV + pembro periop (MIBC) 🔹 LBA8: ctDNA-guided atezo (MIBC) 🔹 LBA87: Enza in biochem recurrent PCa 🔹 LBA93: Durva ± treme (adjuvant RCC) 📺 Full coverage soon on
0
2
8
🫁 Top #LungCancer abstracts at #ESMO25 via High5OncologyTV: 🔹 LBA4: Ivonescimab vs Tislelizumab (sqNSCLC) 🔹 LBA5: Sac-TMT vs chemo (EGFRm NSCLC) 🔹 2757O: Tarlatamab + chemo-IO (ES-SCLC) 🔹 LBA65: Neoadj Durva + CT (IIB–IIIB NSCLC) 🔹 LBA74: Zongertinib 1L (HER2m) 🔹 LBA69:
0
11
17
🚨 Top #BreastCancer data from #ESMO2025: 🔬 291O (DESTINY-Breast11): HER2-low & beyond 🔥 LBA20 (ASCENT-3): Sacituzumab solidifies its role 📈 LBA13 (monarchE): Abemaciclib updates 🔁 LBA14 (NATALEE): Duration matters ⚡ LBA17 (VIKTORIA-1): Next-gen ADCs emerge @evaciruelos
2
11
32
🚨 #ESMO25 is near! What #lungcancer data is @StephenVLiu watching? Highlights include: 🔹 HARMONi-6 (LBA4) 🔹 OptiTROP-Lung04 (LBA5) 🔹 ALINA (1787MO) 🔹 KEYNOTE-671 (LBA67) 🔹 BR.31 (LBA68) 🔹 AEGEAN (LBA70) 🔹 LAURA (1817MO) Watch on #high5oncologyTV Oct 19! #NSCLC #oncology
0
4
8
🎥 ESMO 2025 is almost here! Dr. Peter Goebell shares a warm welcome from high5oncologyTV as we gear up to bring you expert insights and real-time updates from this year’s ESMO Congress in Berlin 🇩🇪. 📍Whether you're attending in person or tuning in from afar, our panel of
0
1
1
Looking forward to #esmo2025! What are the highlights in #GUcancers for Axel S. Merseburger, MD @amerseburger? All exciting results and data presented by experts available on October 19th on #high5oncologcyTV - stay tuned!
0
2
3
The latest data from #uegweek discussed by the #high5immunologyTV experts. Watch now - for free and on demand: https://t.co/TKaBzEI4Hr
@silvio_silvio75 @DignassAxel @MatthieuAllez @FernandoMagro6 @UegWeek
0
2
3
What were the latest updates at #uegweek 2025? Find out on #high5immunologyTV - now for free and on demand: https://t.co/TKaBzEICwZ
0
3
3
Today reporting live from @UegWeek for our partners #high5immunologyTV: Silvio Danese, MD. Reports coming soon on https://t.co/TKaBzEICwZ, stay tuned! @silvio_silvio75
0
1
1
our partner #high5immunology.tv is reporting from #uegweek2025 Stay tuned for the latest #IBD content soon online: https://t.co/LEuhcCk1F8
0
1
1
🧬 ESMO 2025: Abstract titles now available! The countdown has begun – get an early look at the most anticipated oncology studies. high5oncologyTV will be covering the highlights once again! 📅 Starting October 19, explore in-depth congress reports, expert interviews, and
0
1
2
Recap: June was packed with new updates! We were at ASCO – from groundbreaking presentations to the latest FDA approvals. Swipe through for a fast-track overview of clinical highlights, fresh data, and key milestones! #ASCO #Oncology #CancerResearch #ClinicalTrials
0
2
3